BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,464,220 | -8.2% | 8,726,000 | -7.0% | 0.69% | +7.0% |
Q2 2023 | $9,219,566 | -35.9% | 9,386,000 | -33.0% | 0.65% | -35.9% |
Q1 2023 | $14,383,199 | -2.7% | 14,019,000 | +0.7% | 1.01% | +7.8% |
Q4 2022 | $14,780,730 | +4.6% | 13,927,000 | -2.3% | 0.94% | -1.3% |
Q3 2022 | $14,128,000 | +20.1% | 14,257,000 | +20.0% | 0.95% | +28.4% |
Q2 2022 | $11,761,000 | +29.7% | 11,878,000 | +30.9% | 0.74% | +49.3% |
Q1 2022 | $9,068,000 | -3.0% | 9,071,000 | +1.4% | 0.50% | -9.7% |
Q4 2021 | $9,351,000 | +1987.3% | 8,944,000 | +1914.4% | 0.55% | +1612.5% |
Q1 2021 | $448,000 | -19.9% | 444,000 | -14.9% | 0.03% | -20.0% |
Q4 2020 | $559,000 | -92.1% | 522,000 | -92.3% | 0.04% | -93.5% |
Q3 2020 | $7,079,000 | -45.8% | 6,747,000 | -36.9% | 0.61% | -46.6% |
Q2 2020 | $13,070,000 | +85.2% | 10,695,000 | +57.7% | 1.14% | +84.1% |
Q1 2020 | $7,058,000 | -11.0% | 6,781,000 | -9.7% | 0.62% | +17.8% |
Q4 2019 | $7,932,000 | +14.7% | 7,511,000 | +6.8% | 0.53% | +5.0% |
Q3 2019 | $6,915,000 | -6.6% | 7,035,000 | -1.4% | 0.50% | -8.5% |
Q2 2019 | $7,407,000 | +17.1% | 7,135,000 | +15.4% | 0.55% | +3.8% |
Q1 2019 | $6,328,000 | +1.9% | 6,185,000 | -1.0% | 0.53% | -8.8% |
Q4 2018 | $6,210,000 | -3.3% | 6,245,000 | +2.7% | 0.58% | +17.4% |
Q3 2018 | $6,421,000 | – | 6,083,000 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 29,791,000 | $29,160,000 | 1.77% |
PFM Health Sciences, LP | 45,910,000 | $45,566,000 | 1.74% |
Cheyne Capital Management (UK) LLP | 1,500,000 | $1,486,000 | 1.26% |
SSI INVESTMENT MANAGEMENT LLC | 11,878,000 | $11,761,000 | 0.74% |
Sonora Investment Management Group, LLC | 6,550,000 | $6,527,000 | 0.62% |
ADVENT CAPITAL MANAGEMENT /DE/ | 34,005,000 | $33,750,000 | 0.60% |
PALISADE CAPITAL MANAGEMENT, LP | 10,703,000 | $10,595,000 | 0.29% |
MACKAY SHIELDS LLC | 11,419,000 | $11,304,000 | 0.27% |
BNP Paribas Asset Management Holding S.A. | 4,175,000 | $70,578,000 | 0.27% |
RWC Asset Management LLP | 8,200,000 | $8,143,000 | 0.26% |